For research use only. Not for therapeutic Use.
MHY-1685, a novel mammalian target of rapamycin (mTOR) inhibitor, provides opportunities to improve hCSC-based myocardial regeneration.
| Catalog Number | I045238 |
| CAS Number | 27406-31-1 |
| Synonyms | 5-[(4-hydroxyphenyl)methylidene]-1,3-diazinane-2,4,6-trione |
| Molecular Formula | C11H8N2O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C11H8N2O4/c14-7-3-1-6(2-4-7)5-8-9(15)12-11(17)13-10(8)16/h1-5,14H,(H2,12,13,15,16,17) |
| InChIKey | KSOJQSBHVKAHPC-UHFFFAOYSA-N |
| SMILES | C1=CC(=CC=C1C=C2C(=O)NC(=O)NC2=O)O |
| Reference | [1]. Park JH, et al. Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair. Exp Mol Med. 2021 Sep;53(9):1423-1436. |
